BIOLIFE SOLUTIONS INC — Director's Dealing 2020

Nov 17, 2020

SEC Form 4/A — Form 4/A

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2020-07-22

Reporting Person: DE GREEF RODERICK (CFO & COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-22	Common Stock	A	100000	—	Acquired	158074	Direct

Footnotes

F1: This Form 4/A is being filed to amend the Form 4 (the "Original Form 4") filed by the reporting person on July 24, 2020 to include the restricted stock grant that was granted on July 22, 2020 pursuant to the BioLife Solutions Inc. Second Amended and Restated 2013 Performance Incentive Plan, on Table I rather than Table II. As described in the Original Form 4, the restricted stock vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The information included in column 5 of this Form 4/A reflects the number of securities beneficially owned following the reported transaction on July 22, 2020 assuming all of the restricted shares vested.